These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33790127)

  • 1. Trends, Treatment Approaches, and In-Hospital Mortality for Acute Coronary Syndrome in Japan During the Coronavirus Disease 2019 Pandemic.
    Morishita T; Takada D; Shin JH; Higuchi T; Kunisawa S; Imanaka Y
    J Atheroscler Thromb; 2022 May; 29(5):597-607. PubMed ID: 33790127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan.
    Watanabe S; Shin JH; Morishita T; Takada D; Kunisawa S; Imanaka Y
    J Atheroscler Thromb; 2022 Nov; 29(11):1571-1587. PubMed ID: 34924456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan　- Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease.
    Ishii H; Amano T; Yamaji K; Kohsaka S; Yokoi H; Ikari Y
    Circ J; 2020 Nov; 84(12):2185-2189. PubMed ID: 32963133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 pandemic on emergency medical system and management strategies in patients with acute coronary syndrome.
    Saiin K; Takenaka S; Nagai T; Takahashi A; Mizuguchi Y; Konishi T; Anzai T; Hotta D; Kamigaki M; Yamazaki S; Fujita T; Yamashita T; Kawahatsu K; Suzuki T; Nozaki Y; Sakurada T; Takenaka T; Igarashi Y; Makino T;
    Sci Rep; 2023 Mar; 13(1):5120. PubMed ID: 36991026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Pandemic Impact on Percutaneous Coronary Intervention for Acute Coronary Syndromes: An Australian Tertiary Centre Experience.
    Ramzy J; Martin CA; Burgess S; Gooley R; Zaman S
    Heart Lung Circ; 2022 Jun; 31(6):787-794. PubMed ID: 35165052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on acute coronary syndromes.
    Perrin N; Iglesias JF; Rey F; Benzakour L; Cimci M; Noble S; Degrauwe S; Tessitore E; Mach F; Roffi M
    Swiss Med Wkly; 2020 Dec; 150():w20448. PubMed ID: 33382905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital outcome in patients presenting with acute coronary syndrome with left main coronary artery disease: A report from Japanese prospective multicenter percutaneous coronary intervention registry.
    Tani H; Sawano M; Numasawa Y; Kobayashi Y; Suzuki M; Noma S; Shiraishi Y; Ueda I; Fukuda K; Kohsaka S
    J Cardiol; 2020 Jun; 75(6):635-640. PubMed ID: 31899113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England.
    Rashid M; Wu J; Timmis A; Curzen N; Clarke S; Zaman A; Nolan J; Shoaib A; Mohamed MO; de Belder MA; Deanfield J; Gale CP; Mamas MA
    J Intern Med; 2021 Jul; 290(1):88-100. PubMed ID: 33462815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-2020.
    Alekyan BG; Boytsov SA; Manoshkina EM; Ganyukov VI
    Kardiologiia; 2021 Dec; 61(12):4-15. PubMed ID: 35057716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in incidence and outcome of acute coronary syndrome.
    Neumann JT; Goßling A; Sörensen NA; Blankenberg S; Magnussen C; Westermann D
    Clin Res Cardiol; 2020 Sep; 109(9):1186-1192. PubMed ID: 32034482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic.
    Matsushita K; Hess S; Marchandot B; Sato C; Truong DP; Kim NT; Weiss A; Jesel L; Ohlmann P; Morel O
    J Thromb Thrombolysis; 2021 Jul; 52(1):95-104. PubMed ID: 33200333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on percutaneous coronary intervention for acute coronary syndromes during the COVID-19 outbreak in a non-overwhelmed European healthcare system: COVID-19 ACS-PCI experience in Ireland.
    Connolly NP; Simpkin A; Mylotte D; Crowley J; O'Connor S; AlHarbi K; Kiernan T; Arockiam S; Owens P; John A; Blake GJ; Fitzgerald S; Cadogan D; Rosseel L
    BMJ Open; 2021 Apr; 11(4):e045590. PubMed ID: 33811055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
    Gluckman TJ; Wilson MA; Chiu ST; Penny BW; Chepuri VB; Waggoner JW; Spinelli KJ
    JAMA Cardiol; 2020 Dec; 5(12):1419-1424. PubMed ID: 32766756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic.
    Zuo M; Xiang S; Bhattacharyya S; Chen Q; Zeng J; Li C; Deng Y; Siu C; Yin L
    BMC Cardiovasc Disord; 2022 May; 22(1):242. PubMed ID: 35614403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and outcomes of percutaneous coronary intervention during the COVID-19 pandemic in Michigan.
    Azzalini L; Seth M; Sukul D; Valle JA; Daher E; Wanamaker B; Tucciarone MT; Zaitoun A; Madder RD; Gurm HS
    PLoS One; 2022; 17(9):e0273638. PubMed ID: 36156591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort.
    Kwok CS; Gale CP; Curzen N; de Belder MA; Ludman P; Lüscher TF; Kontopantelis E; Roebuck C; Denwood T; Burton T; Hains J; Deanfield JE; Mamas MA
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009654. PubMed ID: 33138626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ＜Editors' Choice＞ Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan.
    Kudo N; Tanaka A; Ishii H; Uemura Y; Takagi K; Iwama M; Yoshida R; Ohashi T; Kawai H; Negishi Y; Umemoto N; Tanaka M; Watarai M; Yoshioka N; Morishima I; Noda T; Yoshida Y; Tatami Y; Muramatsu T; Tanaka T; Tashiro H; Takada Y; Izawa H; Watanabe E; Murohara T
    Nagoya J Med Sci; 2021 Nov; 83(4):697-703. PubMed ID: 34916714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan.
    Akita K; Inohara T; Yamaji K; Kohsaka S; Numasawa Y; Ishii H; Amano T; Kadota K; Nakamura M; Maekawa Y
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):231-238. PubMed ID: 31593213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cases of acute coronary syndrome and presumed cardiac death prior to arrival at an urban tertiary care hospital in Pakistan during the COVID-19 pandemic.
    Sheikh S; Van Cleve W; Kumar V; Peerwani G; Aijaz S; Pathan A
    PLoS One; 2022; 17(2):e0263607. PubMed ID: 35113963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.